American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$310M |
| 2 |
AbbVie
ABBV
|
+$279M |
| 3 |
L3Harris
LHX
|
+$251M |
| 4 |
VeriSign
VRSN
|
+$238M |
| 5 |
Jacobs Solutions
J
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$510M |
| 2 |
Texas Instruments
TXN
|
+$504M |
| 3 |
Adobe
ADBE
|
+$416M |
| 4 |
PayPal
PYPL
|
+$378M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$295M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.49% |
| 2 | Financials | 14.96% |
| 3 | Healthcare | 14.78% |
| 4 | Consumer Discretionary | 11.09% |
| 5 | Industrials | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
BCB Bancorp
BCBP
$161M
| $1.48M | ﹤0.01% |
86,862
+20,036
| +30% | +$372K |
|
1527
KRONOS Worldwide
KRO
$905M
| $1.48M | ﹤0.01% |
80,288
+52,817
| +192% | +$903K |
|
1528
Adaptive Biotechnologies
ADPT
$3.89B
| $1.47M | ﹤0.01% |
181,691
+2,065
| +1% | +$18.2K |
|
1529
Ambev
ABEV
$43.5B
| $1.47M | ﹤0.01% |
585,365
+81,392
| +16% | +$232K |
|
1530
Carlisle Companies
CSL
$15.2B
| $1.46M | ﹤0.01% |
6,113
-27,277
| -82% | -$6.79M |
|
1531
Commault Systems
CVLT
$6.26B
| $1.46M | ﹤0.01% |
23,191
+115
| +0.5% | +$7.14K |
|
1532
Loews
L
$23.1B
| $1.46M | ﹤0.01% |
24,614
+4,935
| +25% | +$310K |
|
1533
Toro Company
TTC
$9.32B
| $1.46M | ﹤0.01% |
19,222
+1,946
| +11% | +$158K |
|
1534
Covenant Logistics
CVLG
$865M
| $1.46M | ﹤0.01% |
116,002
+25,312
| +28% | +$272K |
|
1535
Gentex
GNTX
$4.93B
| $1.45M | ﹤0.01% |
51,776
+6,087
| +13% | +$177K |
|
1536
Fortune Brands Innovations
FBIN
$5.83B
| $1.45M | ﹤0.01% |
28,301
-1,245
| -4% | -$73K |
|
1537
Alector
ALEC
$228M
| $1.45M | ﹤0.01% |
142,283
+1,396
| +1% | +$13.9K |
|
|
MCBC
1538
DELISTED
Macatawa Bank Corp
MCBC
| $1.44M | ﹤0.01% |
163,303
+32,929
| +25% | +$294K |
|
1539
Imperial Oil
IMO
$64B
| $1.44M | ﹤0.01% |
30,563
-53,886
| -64% | -$2.75M |
|
1540
Takeda Pharmaceutical
TAK
$55.6B
| $1.44M | ﹤0.01% |
102,425
+31,645
| +45% | +$452K |
|
|
TWTR
1541
DELISTED
Twitter, Inc.
TWTR
| $1.44M | ﹤0.01% |
38,466
-1,128,579
| -97% | -$48.4M |
|
1542
Cushman & Wakefield Ltd
CWK
$3.24B
| $1.44M | ﹤0.01% |
94,188
+42,852
| +83% | +$753K |
|
1543
Qorvo
QRVO
$8.67B
| $1.43M | ﹤0.01% |
15,191
-160,675
| -91% | -$17.3M |
|
1544
John Wiley & Sons Class A
WLY
$2.63B
| $1.43M | ﹤0.01% |
29,910
-1,220
| -4% | -$62.3K |
|
1545
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.37B
| $1.43M | ﹤0.01% |
37,666
-3,068
| -8% | -$122K |
|
1546
Newell Brands
NWL
$2.62B
| $1.43M | ﹤0.01% |
74,866
+10,270
| +16% | +$218K |
|
1547
BWX Technologies
BWXT
$15.8B
| $1.42M | ﹤0.01% |
25,823
+11,082
| +75% | +$576K |
|
1548
World Acceptance Corp
WRLD
$884M
| $1.42M | ﹤0.01% |
12,638
+1,929
| +18% | +$303K |
|
1549
Molson Coors Class B
TAP
$7.75B
| $1.42M | ﹤0.01% |
25,966
+7,504
| +41% | +$403K |
|
1550
MKS Inc
MKSI
$20.7B
| $1.41M | ﹤0.01% |
13,743
-1,139
| -8% | -$133K |
|
Similar funds
American Century Companies's Q2 2022 Portfolio in Review
As of Q2 2022, American Century Companies held 2,437 positions worth $122B, down 16% from $146B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
American Century Companies's Q2 2022 filing shows 146 new, 1,442 increased, 596 reduced and 133 closed positions. Its largest new stake was Maravai LifeSciences: 2,396,740 shares worth $68.1M. The largest sale was Meta Platforms (Facebook), an estimated $510M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q2 2022 buy was Maravai LifeSciences: 2,396,740 shares worth $68.1M.
- American Century Companies added most to NVIDIA in Q2 2022, an estimated $310M increase.
- American Century Companies's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $510M.
- American Century Companies fully exited iShares Russell Mid-Cap Value ETF in Q2 2022, selling an estimated $278M.
- American Century Companies's ten largest holdings make up 21% of its $122B portfolio in Q2 2022.
- American Century Companies opened 146 new positions and closed 133 in Q2 2022.
- American Century Companies's portfolio value fell 16% quarter-over-quarter to $122B.
Based on American Century Companies's 13F filing for Q2 2022, filed 12 Aug 2022.